Norris Medicines share news, announcements and annual reports
BSE: 524414Commercial Services & SuppliesSmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹14.62.
30 Oct: open ₹14.61, high ₹15.35, low ₹14.02
- Under BSE's graded surveillance, stage 0, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹14 Cr4,400th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 0.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 309
Norris Medicines share news and announcements
394 announcements, routine notices left out, newest first. Page 7 of 8.
Jul 2018
9 Jul · Statement Of Investor Complaints For The Quarter Ended June 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 1 1 0
May 2018
26 May · Audited Financial Statement For The Year Ended 31.03.2018
Apr 2018
21 Apr · Half Yeraly Certificate_ Regl. 40(9)_31.03.2018
20 Apr · Shareholding for the Period Ended March 31, 2018
Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click ....14 Apr · Submission Of Certificate Under Regulation 7(3) For The Period Ended 31St March 2018
11 Apr · Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 2 2 0
Feb 2018
2 Feb · Board Meeting On Saturday, 10Th February, 2018
Jan 2018
19 Jan · Shareholding for the Period Ended December 31, 2017
Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click ....8 Jan · SUBMISSION OF STATEMENT OF INVESTOR COMPLAINT UNDER REGULATION 13(3) OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 FOR THE QUARTER ENDED 31St DECEMBER, 2017
Nov 2017
6 Nov · Board Meeting Held On Thursday, 16Th November, 2017
Oct 2017
13 Oct · Submission Of Certificate Under Reg. 40(9) For The Period Ended September 30, 2017
12 Oct · Shareholding for the Period Ended September 30, 2017
Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click ....11 Oct · Reg.7 (3) _Half Yearly Certificate_30.09.2017
4 Oct · Statement Of Investor Complaints For The Quarter Ended 30.09.2017
Sep 2017
27 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Aug 2017
Jul 2017
17 Jul · Shareholding for the Period Ended June 30, 2017
Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click ....13 Jul · Statement Of Investor Complaint For The Month Of June, 2017
May 2017
29 May · Board meeting
Apr 2017
20 Apr · Shareholding for the Period Ended March 31, 2017
Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click ....13 Apr · Submission Of Certificate Under Regulation 40(10) Of SEBI (LODR) Regulations, 2015 For The Half Year Ended 31St March, 2017
7 Apr · Statement Of Investor Complaint Under Regulation 13 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015 For The Quarter Ended 31St March, 2017.
Mar 2017
Feb 2017
Jan 2017
16 Jan · Shareholding for the Period Ended December 31, 2016
Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click ....14 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Nov 2016